These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 14681681

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM, Welch J, Hayward NK.
    Cancer Res; 2001 Feb 01; 61(3):1154-61. PubMed ID: 11221846
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
    Lilleberg SL, Durocher J, Sanders C, Walters K, Culver K.
    Ann N Y Acad Sci; 2004 Jun 01; 1022():250-6. PubMed ID: 15251969
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
    Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
    Clin Cancer Res; 2003 Dec 15; 9(17):6483-8. PubMed ID: 14695152
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. p53 and RAS gene mutations in multiple myeloma.
    Portier M, Molès JP, Mazars GR, Jeanteur P, Bataille R, Klein B, Theillet C.
    Oncogene; 1992 Dec 15; 7(12):2539-43. PubMed ID: 1461658
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CDKN2A mutation and deletion status in thin and thick primary melanoma.
    Cachia AR, Indsto JO, McLaren KM, Mann GJ, Arends MJ.
    Clin Cancer Res; 2000 Sep 15; 6(9):3511-5. PubMed ID: 10999737
    [Abstract] [Full Text] [Related]

  • 20. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
    Ariyanayagam-Baksh SM, Baksh FK, Swalsky PA, Finkelstein SD.
    Mod Pathol; 2003 Oct 15; 16(10):992-5. PubMed ID: 14559981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.